FED Comments Focus On “Bubble” Stocks In Social Media and Biotech…. Update-1
Update 8PM EDT NASDAQ Holds Losses to 0.54%-Futures Stable Biotech Damage Across the Sector-Rayno Life Science Portfolio Notes Large Caps off about 2% (FBT), but Gilead (GILD) down only 0.95% and Roche (RHHBY) up 0.28%. Rayno Biopharma stocks all red down 3-4% with XBI down 3.86%, IBB down...
Tepid Rally Favors Large Caps: ABBV, GILD, RHHBY
Healthcare Stocks trail other sectors up 0.34%, Energy up 0.8%, Financials up 0.73% and Technology up 0.77% But biotech ETFs are in the Green Biotechnology stocks were mixed today with the following winners among our large cap picks: Gilead Sciences (GILD) up 1.26%, Roche Holding (RHHBY) up...
Risk Off: Take Profits in Biotech Stocks… Update -1
Re-iterate call from Tuesday....futures down 0.8%-Russell down 2%, gold up, Japan and Europe down.. Bad Tape Yesterday (7/7) Calls For Raising Cash NASDAQ at 4451 up 6.58% YTD Major ETFs and Fidelity (FBIOX) take a ~3% hit All major market sectors weak with healthcare down 1% Unusual weakness...
Rayno Life Sciences: First Half Stock Performance Part 2-ILMN, SQNM
Rayno Diagnostics and Tools-Sequencing Rules Diagnostics and Tools stocks tracked biotech stocks during the huge moves in January/February and sold off until the April bottom. However stocks that are more revenue and earnings driven -Cardiovascular Systems(CSII) and Quidel (QDEL)- did not...
Rayno Life Sciences: First Half Stock Performance Part I-ACHN, AMRI, VRTX
Biopharmaceutical Stocks Come Roaring Back After Q1 Correction Most Stocks Bottomed in April -We are Currently in Rally Mode The biotech sector is up 18% YTD as tracked by most popular ETFs (FBT,IBB,XBI). After a vicious sell-off from the February bubble the biotech sector bottomed in April and...